We report here the isolation of a-glucosidase (A G H ) inhibitory peptides derived from sardine muscle hydrolyzate, which was prepared by digestion with Bacillus licheniformis alka line protease. A s a result of reversed-phase HPLC purification, two A G H inhibitory peptides were isolated from a D EA E -Sephadex A-25 column eluate. The peptides were identified as follows: V al-Trp (IC50 = 22.6 mM) and T ry -T y r -P r o -L e u (IC50 = 3.7 mM). A G H inhibitory studies of T r y -T y r -P r o -L e u and its derivatives demonstrated the importance of the tri peptide chain length as well as the hydrophobic aromatic amino acid tyrosine at the N-terminus, aliphatic amino acids at the C-terminus, as well as an amide proton from the peptide chain at the middle position of the tri-peptide to develop AGH inhibition activity.
Introduction
Developments of therapeutic drugs are under way for the prophylaxis and various clinical thera peutic treatm ents of the noninsulin-dependent di abetes mellitus (NIDDM ) or its combined diseases such as retinopathy, neuropathy, and cataracts (Kageyama, 1996) . Am ong them, one of the most direct and beneficial therapy for NIDDM that achieves optimum blood glucose control after a meal is the delay of glucose absorption (Bischoff, 1994; Toeller, 1994) , and potent a-glucosidase (AG H, EC 3.2.1.20) inhibitors such as acarbose or voglibose fulfill these dem ands (Odaka et al, 1992) . Contrary to these synthetic inhibitors, the inhibitors from food com ponents would be benefi cial by taking into account the improvement of quality of life.
In our previous paper (Matsui et a l, 1996) , we have examined AGH inhibition potency of various foodstuffs, in which Bacillus licheniformis alkaline protease hydrolyzate from sardine muscle (IC50 = 48.7 mg/ml) as well as green and oolong teas (IC50 = 11.1 and 11.3 mg/ml, respectively) strongly retarded the cleavage of p-nitrophenyl a-D-glucopyranoside (P N P -G ) as a synthetic substrate. In Reprint requests to Dr. T. Matsui. Fax: + 8 1 -9 2 -6 4 2 3 0 3 0 E-mail: tmatsui@agr.kyushu-u.ac.jp addition, the hydrolyzates prepared by other pro teases (pepsin, trypsin, and denazyme AP) had a distinct inhibitory activity towards AGH. This finding strongly suggests that the inhibitors in sar dine muscle hydrolyzate may be peptidic com pounds newly produced by action of protease, and not naturally occurring compounds.
There have been a few reports with respect to AGH inhibitors from foodstuffs, and natural polyphenolic inhibitors have been identified from Tochu-cha (W atanabe et a l, 1997) and oolong tea (Nakahara et a l, 1993). D-Xylose as a food interigent was also found to have an in vivo suppression effect against the increase of portal plasma glucose in Sprague-Dawley rats (M atsuura et a l, 1997). Contrary to these studies regarding naturally occurring inhibitors, there is no report on pep tides with AGH inhibitory activity. Thus, in this study, we have tried to isolate and identify the peptidic AGH inhibitors in sardine muscle hydro lyzate by high-performance liquid chrom atogra phy (HPLC).
Materials and Methods

Materials
a-Glucosidase from bakers yeast (AGH, 9 U/mg) were purchased from Sigma Chemicals Co. (MO, U.S.A.) and synthetic substrate, p-nitrophenyl a -Dglucopyranoside (P N P -G ) was from E. Merck 0939-5075/99/0300-0259 $ 06.00 © 1999 Verlag der Zeitschrift für Naturforschung, Tübingen • www.znaturforsch.com. D (Darm stadt, Germany). One unit is defined as the amount of AGH to hydrolyze 1 pmol of P N P -G per min at pH 6.8 at 37 °C. Bacillus licheniformis alkaline protease was obtained from Novo. Co. (2.4L, type FG, Chiba, Japan). All other chemicals were obtained from Nacalai Tesque (Kyoto, Japan) and used without purification.
Preparation o f alkaline protease sardine muscle hydrolyzate
Sardine muscle (10 g) supplied by Senmi Ekisu Co. (Ozu, Japan) was hydrolyzed under incubation condition with 0.3 wt% protease for 17 h at 50 °C by the same procedure as described in our previ ous paper (Matsui et al., 1996) . A fter centrifuging at 1000 g, the supernatant was lyophylized.
Fractionation o f the hydrolyzate by column chromatography
The lyophilizate (0.4 g) redissolved in 50 ml of 0.1m phosphate buffer (pH 7.8) was applied to DEAE-Sephadex A-25 (O H -form, Pharmacia LKB, Co., Tokyo, Japan) column ( 0 3.0x7.5 cm) in order to obtain more potent AGH inhibitory fractions. The active fractions eluted by a stepwise gradient (300 ml) with 0.1 and 0.3 m NaCl in 0.1 m phosphate buffer (pH 7.8) denoted as fractions B and D, respectively, were collected, and dialyzed against distilled water with a Spectra/Por m em brane (< 100 MW, Funakoshi Co., Tokyo, Japan).
Purification o f A G H inhibitors
AGH inhibitors in the fractions B and D were then subjected to the HPLC purification. At the first step of HPLC (Shimadzu LC-10AD instru ment, Kyoto, Japan), each sample was applied on a TSK gel ODS-120T column ( 0 0.78 x 30 cm, Tosoh Co., Tokyo, Japan) and eluted with a linear gradient of acetonitrile (5 to 50% for 45 min) at a flow rate of 1.0ml/min. The fraction with potent AGH inhibitory activity was concentrated by the evaporation under reduced pressure. The concen trate was then put directly to a phenyl silica col umn 0 0.46x25 cm, Cosmosil 5Ph, Nacalai Tesque Co., Kyoto, Japan), and eluted with a linear gra dient of acetonitrile (5 to 50% for 45 min) at a flow rate of 0.5 ml/min. Final chromatography of active fraction from a 5Ph column was performed on a C 18 column ( 0 0.46 x 25 cm, Cosmosil 5C 18-AR II, Nacalai Tesque Co., Kyoto, Japan), and eluted with a linear gradient of acetonitrile (18 to 21% for 30 min) containing 0.1% trifluoroacetic acid at a flow rate of 0.5 ml/min.
Identification and synthesis o f isolated A G H inhibitors
The amino acid composition and sequence were analyzed with a Shimadzu LC-6A amino acid ana lyzer, and a Shimadzu PPSQ-21 protein se quencer, respectively.
Identified peptide and its analogs were synthe sized using Fmoc solid phase synthesis on a Kokusan Peptide Synthesizer (Kokusan Chemical Works Ltd., Tokyo, Japan).
Assay for A G H inhibitory activity
AGH inhibitory activity was determ ined by the procedure reported elsewhere (M atsui et al., 1996) using P N P -G as a substrate. Briefly, 10 pi of the AGH inhibitor and 40 pi of 32 mU AGH solution in a 50 mM phosphate buffer (pH 7.0) containing 100 m M NaCl were incubated at 37 °C for 15 min after adding 950 pi of 0.7 m M P N P -G in the buffer. After being stopped by adding 1.0 ml of a 0.5 m Tris (tris(hydroxymethyl)aminomethane) so lution, the absorbance of PNP released from P N P -G at 400 nm was measured. The inhibitory ratio (% ) to evaluate the A G H inhibitory activity can be calculated as follows:
where Ac , A s, and A B represent the absorbance of the control, sample, and blank, respectively. The concentration of AGH inhibitor required to in hibit 50% of the AGH activity under the assay conditions is defined as the IC50 value.
In the kinetics m easurement, the final concen tration of P N P -G was set in the range of 0.1 mM to 1.0 m M . The inhibition mode was determ ined from the Lineweaver-Burk plot.
Results and Discussion
Isolation and identification o f A G H inhibitors from sardine muscle hydrolyzate
In a previous paper (Matsui et al., 1996) , we have shown that the fractions B (IC50 = 16.5 mg/ ml) and D (IC50 = 15.6 mg/ml) on a DEAE-Sephadex A-25 column eluted with 0.1 and 0.3 m NaCl in 0.1 m phosphate buffer (pH 7.8), respectively, showed higher inhibitory activity against yeast AGH than the original hydrolyzate (IC50 = 48.7 mg/ml). Thus, both fractions were subjected to the HPLC purification to isolate AGH inhibi tory substrates. Fig. 1 shows the elution patterns of fraction B on a TSK gel ODS-120T column, and the relative AGH inhibitory activity. The fraction was sepa rated into two subfractions (elution volume of 12-18 ml and 2 0 -2 4 ml, respectively). Most of the AGH inhibitory activity occurred in both subfrac tions denoted as B-l and B-2, respectively, though minor inhibition was also observed in other parts. The same purification was carried out for fraction D, from which the subfraction, D -l (elution vol ume of 67-71 ml under the same elution condi tion) with potent AG H inhibition was collected (data not shown). These active fractions were used for the next purification step, and the HPLC run monitored at 220 nm was perform ed on a Cosmosil 5Ph column. Fig. 2A shows the chromatogram of fraction B-2, and the active peak (arrow; retention time (RT); 17.9 min) was subjected to a final purifica tion step on a Cosmosil 5C18-AR II column (Fig. 2B ). As shown a single peak with AGH in- The inhibition ratio of each peptide against yeast aglucosidase was evaluated by monitoring the pro duction of PNP from P N P -G as a substrate at 400 nm after incubation at 37 °C for 15 min with or without inhibitor. The IC50 values are expressed as mean ± standard deviation (n = 3).
hibitory activity denoted as B-2a was obtained (RT; 21.9 min). One peak denoted as D -la (RT; 35.2 min) was also isolated from fraction D -l. U n fortunately, we could not isolate active peptides from B-l fraction due to loss or disappearance of AGH inhibitory activity. As a result of amino acid composition and sequence analyses, all of the iso lated AGH inhibitors were found for the first time in a natural protein hydrolyzate as a bioactive pep tide, and identified as V al-T rp (B-2a; IC50 = 22.6 m M ) , and T y r-T y r-P ro -L e u (D -la; IC50 = 3.7 mM) ( Table I ). Inhibitory activity of T y r-T y r-P ro -L e u was ca. 140-fold weaker than that of a voglibose, typical commercial therapeutic drug (Matsui et al., 1996) (IC50 = 26 [.i m , Takeda M edi cal Co., Osaka, Japan). However, considering that the peptides may be used as a physiologically func tional food component, the prophylactic effect in diabetes by food would be substantial, regardless of its lower inhibition. Fig. 3 shows the Lineweaver-Burk plots for the inhibition of AGH by both inhibitory peptides. As a result, both peptides inhibited AGH competitively. Both isolated pep tides were constructed with not more than 4 amino acid residues, agreed with the result that the ap parent molecular weight of the sardine muscle hy drolyzate was ranged from 250 to 1000 (Matsui et al., 1993) .
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Importance o f amino acid residue on the inhibition against A G H
In order to obtain the structural information of peptide required for the AGH inhibition, the rela tionship between the structure of derivatives from the isolated peptide and AGH inhibition was in vestigated (Table II) . T y r-T y r-P ro -L e u which showed a potent inhibition against yeast AGH was selected as a skeleton peptide. As summarized five peptides were synthesized, and the AGH inhibi tion was determined. In comparison with the in hibitory activity of original tetra-peptide (IC50 = 3.7 m M ) , lack of Tyr at the N-terminus of the skele ton peptide did not influence on A G H inhibition power (IC50 = 3.9 m M ) , indicating that the tri- Table II structure, T y r-P ro -L e u , was the essential element for AGH inhibition. In addition, the fact that the di-peptides, P ro -L e u , and T y r-P ro as well as V al-Trp (Table I) showed no or less inhibition strongly suggests that tri-peptide chain length is required to decrease the action of AGH. Since T yr-P ro showed poor inhibition, Leu at the Cterminus was found to be most im portant for bind ing to or interact with the active site of AGH. Sub stitution of Leu by Gly at the C-terminus of T y r-P ro -L e u exhibited a similar A G H inhibition (IC50 = 5.0 m M ) , whereas a 6-fold reduction of in hibition activity was observed with T y r-P ro -T y r (IC50 = 25.8 m M ). These results indicate that ali phatic amino acids, e.g. Leu or Gly at the C-terminus of the tri-peptide was more favorable than aromatic ones to inhibit AGH.
The aglycone of the pradimicin family of anti biotics potently inhibits AGH (Sawada et al., 1993) as well as D-catechin (Nakahara et al., 1993) . So it appears that any AGH inhibitors should include a polyphenolic structure. This speculation was sup-ported by Watanabe et al. (1993) and Nishioka et al. (1997) , who isolated polyphenols and phen olic amides with potent AGH inhibitory activity from Tochu-cha and Welsh onion, respectively. Accordingly, a more effective amino acid at the Nterminus was assumed to be Tyr rather than an aliphatic amino acid. In addition, they have dem onstrated that the existence of an amide proton available close to near the middle of the structure such as N-p-coumaroyltyramine is most effective to develop inhibitory activity (Nishioka et al., 1997) . Therefore, the amide proton from Pro at the middle position of the tri-peptide may be also important for a peptidic inhibitor to enhance its inhibition power, although the contribution of an amide proton to the inhibitory action against AGH has not yet been clarified.
